SALV.L

SalvaRx Group Plc
SalvaRx Group plc - Cancellation of trading on AIM
9th January 2020, 14:30
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3447Z
SalvaRx Group plc
09 January 2020
 

9 January 2020

SalvaRx Group plc

("SalvaRx" or the "Company")

Cancellation of trading on AIM

Further to the Company's announcement of 20 December 2019, SalvaRx confirms that the cancellation of the admission to trading of the Company's ordinary shares on AIM will take effect from 7.00 a.m. on 10 January 2020.

The Board anticipates making a further announcement about a potential acquisition shortly which will, should this transaction proceed, involve a reverse takeover by the Company and re-listing of the Company's ordinary shares.

Enquiries

SalvaRx Group plc

Denham Eke

Tel: +44 (0) 01624 639396

SP Angel Corporate Finance LLP

Nominated Adviser and Broker

Matthew Johnson / Caroline Rowe (Corporate Finance)

Abigail Wayne (Corporate Broking)

Tel: +44 (0) 20 3470 0470

Peterhouse Corporate Finance Limited

Joint Broker

Lucy Williams / Duncan Vasey

Tel: +44 (0) 20 7469 0932

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUPUQGGUPUGCB ]]>
TwitterFacebookLinkedIn